Bethany Sensenig - 21 Apr 2023 Form 4 Insider Report for 9 METERS BIOPHARMA, INC.

Role: Chief Financial Officer
Signature: /s/ Lorna A. Knick, as power of attorney
Issuer symbol: N/A
Transactions as of: 21 Apr 2023
Net transactions value: -$11,011
Form type: 4
Filing time: 21 Apr 2023, 17:08:33 UTC
Previous filing: 29 Mar 2023
Next filing: 21 Aug 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	NMTR	Common stock	Sale	$11,011	-9,100	-18%	$1.21^*	41,077	21 Apr 2023	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Reflects shares sold to cover taxes upon the vesting of restricted stock units on April 15, 2023.
F2	The price reported in column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $1.20 to $1.23. The reporting person undertakes to provide to 9 Meters Biopharma, Inc., any security holder of 9 Meters Biopharma, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote 2 to this Form 4.

Content

Reflects shares sold to cover taxes upon the vesting of restricted stock units on April 15, 2023.

The price reported in column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $1.20 to $1.23. The reporting person undertakes to provide to 9 Meters Biopharma, Inc., any security holder of 9 Meters Biopharma, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote 2 to this Form 4.